COMING SOON

MiniMed logo


MiniMed Go™ is
 FDA cleared


The new smart insulin pen system combines the InPen™ with the 15-day Instinct sensor, made by Abbott. The system remembers, reminds, and recommends — taking on the mental math of daily management.

Read press release →

MiniMed system

Smart device sold separately

The smart pen system making diabetes easier


MiniMed Instinct sensor by Abbott Woman holding a cup in the kitchen

Remembers
doses so you don’t have to!

Man holding an InPen

Reminds
you when you need more insulin.

Girl eating a pizza

Recommends
doses based on trends and active insulin levels.

Get notified when MiniMed Go is available for order this spring.


Sign up to receive email communications when the product becomes available.




Important Safety Information: MiniMed Go™ system

The MiniMed Go app is intended for use with the InPen smart insulin pen and Instinct continuous glucose monitoring (CGM) sensor to aid in diabetes management through multiple daily injections of compatible rapid-acting insulins. The app and system components each require a prescription. When used with Instinct, the app is indicated for patients ages 7 years and older, or patients ages 2 to 6 years under the supervision of an adult caregiver. If using InPen alone, the app is intended for all ages, with patients under age 7 requiring supervision. Use of the system requires, among other things, adequate hearing and vision, a compatible mobile device and operating system, an open app, adequate pairing and connectivity, use of an approved rapid-acting insulin, mobile device battery power, proper settings, accurate manual logging of insulin doses administered by means other than InPen, and occasional blood glucose meter (BGM) readings. Establishment of settings and treatment decisions should be made in consultation with a healthcare professional and on the basis of a combination of glucose readings, trend arrows, glucose target, active alerts, and recent events (such as insulin doses, exercise, meals, and medications). Failure to observe these and other details as found in the user guides can result in incorrect dosing, missed alerts and notifications, and ultimately hypoglycemia or hyperglycemia, with serious injury or death possible. For complete details, consult the appropriate system and component user guides.



© Medtronic. MiniMed and MiniMed logo are trademarks of Medtronic MiniMed, Inc. The sensor shape and appearance, Abbott, and “a” logo are marks and/or designs of the Abbott group of companies in various territories and used under license. Sensor image ©2026 Abbott. ™*Third–party brands are trademarks of their respective owners.